Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
Sharana Mahomed, Nigel Garrett, Disebo Potloane, Izukanji T Sikazwe, Edmund Capparelli, Ishana Harkoo, Tanuja Narayansamy Gengiah, Nonhlanhla Yende Zuma, Farzana Osman, Leila Mansoor, Derseree Archary, Nqobile Myeni, Precious Radebe, Natasha Samsunder, Nicole Doria Rose, Kevin Carlton, Lucio Gama, Richard A Koup, Sandeep Narpala, Leonid Serebryannyy, Penny Moore, Carolyn Williamson, Bruno Pozzetto, Catherine Hankins, Lynn Morris, Quarraisha Abdool Karim, Salim Abdool Karim
BMJ Open Aug 2023, 13 (8) e076843; DOI: 10.1136/bmjopen-2023-076843
